Extremophilic 50S Ribosomal RNA-Binding Protein L35Ae as a Basis for Engineering of an Alternative Protein Scaffold

PLoS One. 2015 Aug 6;10(8):e0134906. doi: 10.1371/journal.pone.0134906. eCollection 2015.

Abstract

Due to their remarkably high structural stability, proteins from extremophiles are particularly useful in numerous biological applications. Their utility as alternative protein scaffolds could be especially valuable in small antibody mimetic engineering. These artificial binding proteins occupy a specific niche between antibodies and low molecular weight substances, paving the way for development of innovative approaches in therapeutics, diagnostics, and reagent use. Here, the 50S ribosomal RNA-binding protein L35Ae from the extremophilic archaea Pyrococcus horikoshii has been probed for its potential to serve as a backbone in alternative scaffold engineering. The recombinant wild type L35Ae has a native-like secondary structure, extreme thermal stability (mid-transition temperature of 90°C) and a moderate resistance to the denaturation by guanidine hydrochloride (half-transition at 2.6 M). Chemical crosslinking and dynamic light scattering data revealed that the wild type L35Ae protein has a propensity for multimerization and aggregation correlating with its non-specific binding to a model cell surface of HEK293 cells, as evidenced by flow cytometry. To suppress these negative features, a 10-amino acid mutant (called L35Ae 10X) was designed, which lacks the interaction with HEK293 cells, is less susceptible to aggregation, and maintains native-like secondary structure and thermal stability. However, L35Ae 10X also shows lowered resistance to guanidine hydrochloride (half-transition at 2.0M) and is more prone to oligomerization. This investigation of an extremophile protein's scaffolding potential demonstrates that lowered resistance to charged chemical denaturants and increased propensity to multimerization may limit the utility of extremophile proteins as alternative scaffolds.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Antibodies / chemistry
  • Antibodies / metabolism
  • Archaeal Proteins / chemistry*
  • Archaeal Proteins / genetics
  • Archaeal Proteins / metabolism
  • Biomimetic Materials / chemistry
  • Biomimetic Materials / metabolism
  • Carrier Proteins / chemistry*
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Cloning, Molecular
  • Escherichia coli / genetics
  • Escherichia coli / metabolism
  • Gene Expression
  • Guanidine / chemistry
  • HEK293 Cells
  • Hot Temperature
  • Humans
  • Models, Molecular
  • Molecular Sequence Data
  • Protein Denaturation
  • Protein Engineering*
  • Protein Multimerization
  • Protein Stability
  • Protein Structure, Secondary
  • Pyrococcus horikoshii / chemistry*
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Ribosomal Proteins / chemistry*
  • Ribosomal Proteins / genetics
  • Ribosomal Proteins / metabolism
  • Ribosome Subunits, Large, Archaeal / chemistry
  • Ribosome Subunits, Large, Archaeal / metabolism

Substances

  • Antibodies
  • Archaeal Proteins
  • Carrier Proteins
  • Recombinant Fusion Proteins
  • Ribosomal Proteins
  • Guanidine

Grants and funding

Programs of the Russian Academy of Sciences "Fundamental science for medicine" (S.E.P.) and "Molecular and cellular biology" (E.A.P.), a grant No. 14-44-03604 from the Russian Foundation for Basic Research and the Ministry of Investments and Innovations of the Moscow region (S.E.P.), and a grant from the Sigrid Jusélius Foundation (A.I.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Antherix provided support in the form of salaries for authors RVM, ABU and TAM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biomirex Inc. provided support in the form of salaries for author TAM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.